InVert Closes RapidGraphite Deal, Widens Battery-Grade Trials

InVert has completed its acquisition of RapidGraphite, securing access to the RapidPulse processing technology and allowing the company to move into larger-scale battery-grade graphite trials.

InVert has completed its acquisition of RapidGraphite, a deal that hands the company control of the RapidPulse processing technology and clears the way for larger-scale trials aimed at producing battery-grade graphite.

The transaction, confirmed as finalised, matters less for its size than for what it removes: the uncertainty of relying on technology the company did not own. With RapidGraphite folded in, InVert now controls the process it intends to build a business around, and can scale test work without renegotiating access rights at every step.

What the RapidGraphite acquisition actually secures

The central asset in the deal is RapidPulse. Graphite processing is the bottleneck in the anode supply chain — not mining it, but turning flake concentrate into the spherical, high-purity coated material that lithium-ion cell makers will accept. That step has historically been dominated by conventional purification routes that are chemically intensive and slow to permit, which is precisely why alternative processing technologies attract capital well before they attract revenue.

By completing the acquisition rather than licensing the technology, InVert takes the intellectual property onto its own balance sheet. That changes the company's negotiating position in three practical ways. It can run trials on its own schedule. It can present a single, integrated technology package to any prospective offtake partner or joint-venture counterparty. And it retains the upside if the process proves itself at scale, rather than sharing it through a royalty.

As Stockhead Resources reported, the completion of the deal is the trigger for the company to step up into larger-scale battery-grade graphite trials — the acquisition and the operational escalation are directly linked.

Why "battery-grade" is the only qualification that counts

Graphite is graded by end use, and the gap between grades is commercial life or death. Industrial graphite — refractories, foundry work, lubricants — is a commodity with modest margins and a mature buyer base. Battery-grade anode material is a specification product: purity thresholds, particle shape, surface coating and electrochemical performance all have to be met, and each cell manufacturer runs its own qualification programme that can take many months of sample testing.

That is the wall every graphite developer eventually hits. Resource statements and metallurgical flowsheets are necessary but not sufficient. What a cell maker wants is repeatable material from a repeatable process, produced at a volume large enough to prove the process did not just work once in a laboratory.

Moving from bench-scale to larger-scale trials is the step where that repeatability gets tested. Scale-up is where processes reveal their weaknesses: yield losses, energy consumption per tonne, reagent handling, waste streams, and the consistency of output when feedstock varies. A technology that performs elegantly on a few kilograms can behave very differently on a continuous run.

The supply-chain backdrop InVert is stepping into

Graphite occupies an unusual position among battery raw materials. By mass it is the largest single input into a typical lithium-ion cell, yet it attracts a fraction of the attention that lithium and nickel command. It is also the input where processing capacity is most heavily concentrated in China — a concentration that has made anode material a recurring subject of Western industrial policy, export-control anxiety and government funding programmes.

That backdrop is why non-Chinese processing technology carries a strategic premium that its current cash flows would not justify. Automakers and cell manufacturers building capacity in North America, Europe and Australia need qualified anode material from outside the dominant supply chain, and there are not many credible routes to it. Any company that can demonstrate a working alternative process at meaningful scale becomes a candidate for partnership conversations far larger than its market capitalisation would suggest.

InVert is not there yet. It is at the stage of proving the process. But the acquisition converts it from a company with an interest in a technology to a company that owns one, and that distinction is the first thing a strategic partner checks.

How the wider market is trading as the deal lands

The completion arrives against a broadly steady session in global equities. As of the last trade at 13:54 GMT on Friday, 21 August 2026, the S&P 500 tracker (NYSEARCA: SPY) was at $764.45, up 0.24% on the day from a previous close of $762.60, with a day range of $764.41 to $766.15. The Dow 30 proxy (NYSEARCA: DIA) was stronger at $530.40, up 0.55% from $527.51. The Nasdaq 100 fund (NASDAQ: QQQ) was flat to marginally lower at $710.78, down 0.02% against a $710.93 prior close.

That mix — industrials and broad-market indices firm, big-cap technology flat — is a mildly supportive tape for resources developers, though small-cap critical-minerals names typically trade on their own news flow rather than index direction. For a company at InVert's stage, the relevant market is not the daily index print but the willingness of specialist investors to fund technical de-risking.

The milestones that will decide whether this works

Investors following the story should watch a short and specific list.

• Trial volumes and continuity. How much material the larger-scale trials process, and whether the runs are continuous rather than batch, will indicate how close RapidPulse is to a commercial configuration.
• Purity and specification results. Published assay and specification data from the scaled trials is the hard evidence. Anything short of battery-grade specification keeps the company in the development bucket.
• Third-party sample testing. Material sent to a cell maker or independent laboratory for qualification carries far more weight than in-house results.
• Operating cost signals. Energy and reagent consumption per tonne determine whether the process can compete with incumbent Chinese purification on cost, not just on provenance.
• Funding. Scale-up costs money. How the company funds the next phase, and on what terms, will shape returns for existing holders.

The acquisition is a completed step, not an outcome. It gives InVert ownership of the tool. The trials now have to show the tool works at a size that a battery supply chain can use.

Key facts

• Transaction: InVert completed the acquisition of RapidGraphite
• Technology secured: RapidPulse graphite processing technology
• Next operational step: Larger-scale battery-grade graphite processing trials
• Market backdrop (last trade 13:54 GMT, 21 Aug 2026): SPY $764.45 (+0.24%); QQQ $710.78 (-0.02%); DIA $530.40 (+0.55%)

Frequently asked questions

What did InVert acquire?

InVert completed the acquisition of RapidGraphite. The central purpose of the transaction was to secure access to the RapidPulse technology, a graphite processing method. Owning the technology outright, rather than licensing it, allows InVert to run and scale its own test programmes without depending on a third party for access rights.

What is RapidPulse technology used for?

RapidPulse is the graphite processing technology InVert obtained through the RapidGraphite acquisition. Graphite processing is the step that converts mined flake concentrate into the high-purity, shaped material that lithium-ion battery anodes require. InVert is now applying the technology in larger-scale trials aimed at producing battery-grade graphite output.

Why does battery-grade graphite matter?

Battery-grade graphite is a specification product rather than a commodity. Cell manufacturers set strict thresholds for purity, particle shape, coating and electrochemical performance, and qualify each supplier through extended sample testing. Industrial-grade graphite carries far lower margins, so reaching battery-grade specification is what separates a developer from a commercial anode-materials supplier.

What is the significance of scaling up processing trials?

Scale-up is where a process proves it is repeatable. Bench-scale results on small samples often fail to translate: yields drop, energy and reagent consumption rise, and output consistency suffers when feedstock varies. Larger-scale trials generate the volume and continuity data that potential offtake partners and cell manufacturers require before they take a technology seriously.

Why is graphite processing strategically important?

Graphite is the largest input by mass in a typical lithium-ion cell, and processing capacity for anode material is heavily concentrated in China. That concentration has made non-Chinese processing routes a focus of industrial policy in North America, Europe and Australia, giving alternative technologies a strategic value beyond their immediate financial performance.

How were markets trading when the deal completed?

As of the last trade at 13:54 GMT on 21 August 2026, the S&P 500 tracker SPY stood at $764.45, up 0.24% from a $762.60 close. The Dow proxy DIA was at $530.40, up 0.55%. The Nasdaq 100 fund QQQ was essentially flat at $710.78, down 0.02% against a $710.93 previous close.

Sources

• InVert to scale-up processing trials on completing RapidGraphite acquisition — Stockhead Resources

Photo: Jess Loiterton · Pexels Licence — source